DNA hypomethylation in inflammatory arthritis: Reversal with methotrexate

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 165-172

  Kim, Young In ^a   Logan, James W ^b   Mason, Joel B ^b   Roubenoff, Ronenn ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030205396     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90008-6     Document Type: Article

References (47)

1. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Engl J Med 1994;330:1368-75.
2. Weinblatt ME, Kaplan H, Germain BF, et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994;37:1492-8.
3. Morgan SL, Baggott JE. Folate antagonists in nonneoplastic disease: proposed mechanisms of efficacy and toxicity. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker, 1995:405-33.
4. Shiroky JB, Yocum DE, Wilder RL, Klippel JH. Experimental basis of innovative therapies of rheumatoid arthritis. In: Cruse JM, Leweis RE, editors. Therapy of autoimmune disease. Concepts in immunopathology. Basel: Karger, 1989: 106-44.
5. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-82.
6. Morgan SL, Baggott JE, Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum 1987;30:1348-56.
7. Weinblatt ME, Fraser P. Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum 1989;32:1592-6.
8. Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate treatment of rheumatoid arthritis. Arthritis Rheum 1990;33:9-18.
9. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:833-41.
10. Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 1991;50:913-14.
11. Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum 1988;31:906-8.
12. Shroky J, Neville C, Esdaile JM, et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1993;36:795-803.
13. Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993;20:950-2.
14. Allegra CJ. Antifolates. In: Chabner BA, Collins JM, editors. Cancer chemotherapy: principles and practice. Philadelphia: JB Lippincott, 1990:110-53.
15. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation of S-adenosyl-methionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-8.
16. Kim Y-I, Miller JW, da Costa K-A, et al. Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J Nutr 1994;124:2197-203.
17. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. Folate deficiency-induced homocysteinemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biochem J 1994;298:415-9.
18. Balaghi M, Horne DW, Wagner C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem J 1993; 291:145-9.
19. Balaghi M, Wagner C. DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Commun 1993; 193:1184-90.
20. Kim, Y-I, Christman JK, Fleet JC, et al. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc specific hypomethylation of colonic DNA in rats. Am J Clin Nutr 1995;61:1083-90.
21. Nesher G, Moore TL. The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum 1990;33:954-9.
22. Razin A, Szyf M. DNA methylation patterns. Formation and function. Biochim Biophys Acta 1984;782:331-42.
23. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-13.
24. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev 1991;55:451-8.
25. Weissbach A, Ward C, Bolden A. Eukaryotic DNA methylation and gene expression. Curr Top Cell Regul 1989;30:1-21.
26. Lewis J, Bird A. DNA methylation and chromatin structure. FEBS Lett 1991;285:155-9.
27. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet 1994;3:1487-95.
28. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983;220:1055-7
29. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthrits. Arthritis Rheum 1988;31: 315-24.
30. Fries JF. The dimensions of health outcomes: the Health Assessment Questionnaire. J Rheumatol 1982;9:786-93.
31. Franklin JL, Rosenberg IH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (azulfidine). Gastroenterology 1973;64:517-25.
32. Selhub J, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine. J Clin Invest 1978;61:221-4.
33. Camp VB, Chipponi J, Faraj BA. Radioenzyme assay for direct measurement of plasma pyridoxa 5′-phosphate. Clin Chem 1983;29:642-4.
34. Roubenoff R, Roubenoff RA, Selhub J, et al. Abnormal vitamin B6 status in rheumatoid cachexia. Association with spontaneous tumor necrosis factor-alpha production and markers of inflammation. Arthritis Rheum 1995;38:105-9.
35. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991;29:549-54.
36. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-71.
37. Kim Y-I, Giuliano A, Hatch KD, et al. Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 1994;74:893-9.
38. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectormetry. J Clin Invest 1988;81:466-74.
39. Hine RJ, Alarcon GS, Koopman WJ, et al. Serum folate (FA) levels of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) or other disease-modifying antirheumatic drugs (DMARDs). Arthritis Rheum 1990;33: S60.
40. Jacob RB, Pianalto FS, Henning SM, Zhang JZ, Swendseid ME. In vivo methylation capacity is not impaired in healthy men during short-term dietary folate and methyl group restriction. J Nutr 1995;125:1495-502.
41. Cedar H. DNA methylation and gene activity. Cell 1988;53: 3-4.
42. Boyes J, Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 1991;64: 1123-34.
43. Tanaka K, Apella E, Jay G. Developmental activation of the H-2K gene is correlated with an increase in DNA methylation. Cell 1983;35:457-65.
44. Gellerson B, Kempf R. Human prolactin gene expression: positive correlation between site-specific methylation and gene activity in a set of human lymphoid cell lines. Mol Endocrinol 1990;4:1874-86.
45. Levine A, Cantoni GL, Razin A. Inhibition of promoter activity by methylation: possible involvement of protein mediators. Proc Natl Acad Sci USA 1991;88:6515-8.
46. Keshet I, Yisraeli J, Cedar H. Effect of regional DNA methylation on gene expression. Proc Natl Acad Sci USA 1985; 82:2560-4.
47. Rachal MJ, Yoo H, Becker FF, Lapeyre J-N. In vitro DNA cytosine methylation of cis-regulatory elements modulates c-Ha-ras promoter activity in vivo. Nucleic Acids Res 1989; 17:5135-47.